Analyst Ratings For NASDAQ:MDCO – The Medicines (NASDAQ:MDCO)
Today, B. Riley initiated coverage on NASDAQ:MDCO – The Medicines (NASDAQ:MDCO) with a Buy with a price target of $55.00.
Some recent analyst ratings include
- 6/7/2018-B. Riley initiated coverage with a Buy rating.
- 3/22/2018-Oppenheimer Reiterated Rating of Buy.
- 2/23/2018-Jefferies Group Reiterated Rating of Buy.
- 1/24/2018-Chardan Capital Reiterated Rating of Buy.
- 1/24/2018-JPMorgan Chase & Co. Reiterated Rating of Overweight ➝ Overweight.
- 1/22/2018-Citigroup Upgrade from a “Neutral ➝ Buy” rating to a “” rating.
- 10/23/2017-Guggenheim initiated coverage with a Buy rating.
- On 5/25/2018 Melvin K Spigelman, Director, sold 7,500 with an average share price of $32.20 per share and the total transaction amounting to $241,500.00.
- On 4/16/2018 Armin M. Kessler, Director, sold 20,000 with an average share price of $28.71 per share and the total transaction amounting to $574,200.00.
- On 3/21/2018 William Crouse, Director, sold 7,500 with an average share price of $32.26 per share and the total transaction amounting to $241,950.00.
- On 12/15/2017 Clive Meanwell, CEO, sold 136,250 with an average share price of $27.24 per share and the total transaction amounting to $3,711,450.00.
- On 12/8/2017 Fredric N Eshelman, Insider, bought 200,000 with an average share price of $26.56 per share and the total transaction amounting to $5,312,000.00.
- On 11/29/2017 Alexander J Denner, Director, bought 170,000 with an average share price of $30.03 per share and the total transaction amounting to $5,105,100.00.
- On 2/7/2017 William Bernard O’connor, CFO, sold 25,833 with an average share price of $46.20 per share and the total transaction amounting to $1,193,484.60.
Recent Trading Activity for NASDAQ:MDCO – The Medicines (NASDAQ:MDCO)
Shares of NASDAQ:MDCO – The Medicines closed the previous trading session at 34.82 up +0.19 0.55% with 35.150001525878906 shares trading hands.